SICC Innvierte fund
Investor profile
Investment firm
SICC Innvierte fund has backed 3 European tech companies across 3 funding rounds in 2026, joining rounds totalling €32M. Most active in Healthtech. Data as of 4 Nov 2026.
Deals
3
distinct rounds
Companies
3
backed
Active span
2026
1 yr
Total round €
€32M
sum of rounds joined
Deals by year
distinct rounds / yearSICC Innvierte fund — deals by year — interactive chart.
Data table
| SICC Innvierte fund — deals by year | |
|---|---|
| 2026 | 3 |
Top sectors
by dealsSICC Innvierte fund — top sectors — interactive chart.
Data table
| SICC Innvierte fund — top sectors | |
|---|---|
| Healthtech | 3 |
Stages
by dealsSICC Innvierte fund — stages — interactive chart.
Data table
| SICC Innvierte fund — stages | |
|---|---|
| Other | 1 |
| Seed | 1 |
| Series A | 1 |
Countries
by dealsSICC Innvierte fund — countries — interactive chart.
Data table
| SICC Innvierte fund — countries | |
|---|---|
| Spain | 3 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Telum Therapeutics | Spain | 1 | €18M |
| ALLOX | Spain | 1 | €9.4M |
| Peptomyc | Spain | 1 | €5.0M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Telum Therapeutics | Series A | €18M | 2026-07 |
| Peptomyc | Other | €5.0M | 2026-04 |